BioMe Inc. announced that it has entered into equity investment agreement with Celltrion, Inc. on December 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
177,900.00 KRW | -0.45% |
|
-1.71% | -5.12% |
02-11 | S.Korean shares end at 3-week high on tariff optimism despite Trump's comments | RE |
02-11 | South Korean shares rise 1% on tariff optimism despite Trump's comments | RE |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- BioMe Inc. announced that it expects to receive funding from Celltrion, Inc.